• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards can’t seem to please The Street | Earnings Roundup

Edwards can’t seem to please The Street | Earnings Roundup

July 22, 2011 By MassDevice staff

Edwards Lifesciences

Shares of Edwards Lifesciences Corp. (NYSE:EW) continued to slide on Wall Street for the second straight day, despite positive earnings and a favorable FDA panel vote that should clear the way for the company to launch the Sapien transcatheter heart valve in the U.S.

During mid-day trading on The Street, shares of the Irvine, Calif.-based Edwards, ranked 46th in the MassDevice Big 100 list of the world’s largest medical device makers, were trading around $78.50 per share, down nearly 5 percent from yesterday’s closing price of $82.55 and down 9 percent from the closing price of $87.53 on July 20.

It isn’t apparent what is causing the sell off; Edwards beat The Street’s expectations during Q2, increasing top line performance by 18 percent to $431.2 million during the three month period ended on June 30, 2011, compared to $365.2 million during the same period last year.

Net income was essentially flat at $58.1 million, compared to $57.5 million for the same period last year.

The company also reaffirmed previous guidance of total sales of $1.66 to $1.74 billion and net income growth of 11 percent to 13 percent, excluding special items.

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Lawsuit woes swallow C.R. Bard’s bottom line
C.R. Bard Inc.’s (NYSE:BCR) share price plummeted nearly 12 percent today after the Murray Hill, N.J.-based company posted Q2 losses on fees paid out in lawsuits against subsidiary Davol Inc.’s hernia repair products.

Bard reported a $47.8 million loss on $725 million in sales during the three month period ended June 30, 2011, reversing a $124.7 million profit on $673.9 million in sales the company reported during the same period last year. Taking out the $184 million legal settlement, the company would have posted 141.7 million in net income , officials said in a prepared release.

On Wall Street, shares of BCR dropped nearly 12 percent from yesterday’s closing price of $112.71.

C.R. Bard ranked #29 on the MassDevice Big 100 list of the world’s largest medical device companies.
Read more

Endologix posts 22 percent sales growth and dramatic losses
Endologix Inc. (NSDQ:ELGX) posted 22 percent growth in sales for the three months ended June 30, 2011, to $19.2 million compared to $15.7 million for the same time last year, crediting strong adoption of its endovascular products and a 30 percent sales boost in the U.S.

The Irvine, Calif.-based company posted a net loss of $13.7 million, or 24 cents per diluted share, an almost 3500 percent increase from the $380,000 net loss in Q2 2010, or 1 cent lost per diluted share. The lion’s share of the loss was attributed to a pending acquisition with Nellix. The company’s losses would have come in at $5.1 million if not for the adjustment.

"We remain encouraged with the continued improvement in our financial performance and progress with the initiatives we have implemented to enhance our commercial, operational, and scientific effectiveness," chairman & CEO Robert Parkinson, Jr. said. "These initiatives, combined with Baxter’s global presence, diversified portfolio, and focus on innovation, provide unique opportunities for future growth in an evolving and challenging macro-environment."
Read more

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: C.R. Bard, Edwards Lifesciences, Endologix, Q2

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy